Severe cutaneous drug toxicity following disitamab vedotin treatment for metastatic gastric cancer: a case report

Severe cutaneous drug toxicity following disitamab vedotin treatment for metastatic gastric cancer: a case report

BackgroundThis study reports a case of severe cutaneous toxicity in a patient with metastatic gastric cancer induced by disitamab vedotin, emphasizing the need for careful monitoring and management in such treatments.Case presentationA 71-year-old female was admitted to hospital complaining of serio...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhao Luping, Cheng Zhen, Li Piaopiao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Oncology
Subjects:	disitamab vedotin case report severe cutaneous drug toxicity adverse effects metastatic gastric cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1504079/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A retrospective multicenter study on the efficacy and safety of disitamab vedotin monotherapy versus combination with anti-PD-1 immunotherapy in advanced gastric cancer
by: Shuailei Dong, et al.
Published: (2025-01-01)

Tumor-shrinking effects of enfortumab vedotin between primary urothelial carcinoma and metastatic organs
by: Daiki Ikarashi, et al.
Published: (2025-01-01)

Cabozantinib Cutaneous Toxicity—Comprehensive Review
by: Cristina Violeta Tutunaru, et al.
Published: (2025-01-01)

Predictive role of ABC transporters in the efficacy of enfortumab vedotin for urothelial carcinoma
by: Toshiki Kijima, et al.
Published: (2025-01-01)

Effectiveness and safety of PD-1/L1 inhibitors as first-line therapy for patients with advanced or metastatic urothelial carcinoma who are ineligible for platinum-based chemotherapy: a meta-analysis
by: Weiming Liang, et al.
Published: (2025-02-01)

Pharmacogenomics predictors of aromatic antiepileptic drugs-induced SCARs in the Iraqi patients
by: Ali Fadhel Ahmed, et al.
Published: (2025-01-01)

Dramatic Response to Enfortumab Vedotin in Soft-tissue Metastases from Urothelial Carcinoma: A Case Report
by: Ming-Hsuan Wu, et al.
Published: (2024-12-01)

Palbociclib-induced Toxic Epidermal Necrolysis: A Case Report with Review of All Cases Secondary to Cyclin-dependent Kinase 4/6 Inhibitors
by: Aurore Devoldere, et al.
Published: (2025-01-01)

Leflunomide induced drug reaction with eosinophilia and systemic symptoms: A lesser known entity
by: Deepak Vashisht, et al.
Published: (2020-01-01)

A Clinico-Epidemiological Study of Cutaneous Adverse Drug Reactions in a Tertiary Care Centre of Eastern India
by: Sujata Sinha, et al.
Published: (2024-01-01)

A Narrative Review on Evaluation of Causal Drug in Cutaneous Drug Eruptions: Challenges, Current State, and the Path Ahead
by: Sivaranjini Ramassamy
Published: (2024-12-01)

Rare skin adverse reactions induced by osimertinib: a case report and literature review
by: Ye Zhang, et al.
Published: (2025-01-01)

A patient-led survey on information and communication needs of patients with metastatic breast cancer in Ireland and Northern Ireland (CTRIAL-IE 23–05)
by: Siobhan Gaynor, et al.
Published: (2025-02-01)

Association of Cutaneous Immune-related Adverse Events with Overall Survival and Progression-free Survival in Oncology Patients Receiving Immune Checkpoint Inhibitors: A Prospective Study of 189 Patients in a Spanish Tertiary Care Hospital
by: Gloria Juan-Carpena, et al.
Published: (2025-01-01)

Risk Factors Analysis of Cutaneous Adverse Drug Reactions Caused by Targeted Therapy and Immunotherapy Drugs for Oncology and Establishment of a Prediction Model
by: Zimin Zhang, et al.
Published: (2025-01-01)

A conceptual model for advanced/metastatic gastric or gastroesophageal junction cancer: a review of qualitative studies and results from patient interviews
by: France Ginchereau Sowell, et al.
Published: (2025-01-01)

Novel combination therapy for platinum-eligible patients with locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysis
by: Takafumi Yanagisawa, et al.
Published: (2025-02-01)

Use of indocyanine green to assess integrity of the gastric wall after repairing the gastric perforation
by: Guoteng Qiu, et al.
Published: (2025-02-01)

Target trial emulation to evaluate the effect of immune-related adverse events on outcomes in metastatic urothelial cancer
by: Renate Pichler, et al.
Published: (2024-12-01)

Combination therapy of low-dose radiotherapy and immunotherapy in advanced metastatic nasopharyngeal carcinoma: a case report and literature review
by: Chun-Qiao Chen, et al.
Published: (2025-01-01)

Shedding New Light on Cutaneous Horns: A Comprehensive Review and Pitfall of Management
by: Leo Wan, et al.
Published: (2025-01-01)

Lamotrigine-Related Skin Rash
by: J. Jokubaitė, et al.
Published: (2023-12-01)

Camrelizumab-induced immune-related toxic epidermal necrolysis in lung adenocarcinoma: a case report and literature review
by: Man Sun, et al.
Published: (2025-01-01)

Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum for the rheumatologist
by: Jyoti Ranjan Parida, et al.
Published: (2019-01-01)

Ascaris lumbricoides a rare cause gastric perforation: a case report and brief literature review
by: Tian-Hao Xie, et al.
Published: (2025-01-01)

Metastatic gastric adenocarcinoma in prostate: A case report
by: Naru Shimizu, et al.
Published: (2025-03-01)

Development and validation of a prognostic nomogram model in primary cutaneous and subcutaneous soft tissue angiosarcoma
by: Jinqian Mao, et al.
Published: (2022-07-01)

Bacterial isolates and drug susceptibility patterns in infected lesions of cutaneous leishmaniasis patients at ALERT hospital, Addis Ababa, Ethiopia
by: Gizealew Ayalew, et al.
Published: (2025-01-01)

Adverse outcome pathway-based assessment of pulmonary toxicity from the in vivo mixture of biocides dinotefuran and cetylpyridinium chloride
by: Yoon Cho, et al.
Published: (2025-01-01)

Risk factors for severe adverse drug reactions in hospitalized patients
by: Petrović Nemanja Z., et al.
Published: (2025-01-01)

Immunotherapy in metastatic renal cell carcinoma: Insights from a Dutch nationwide cohort
by: Hilin Yildirim, et al.
Published: (2025-02-01)

Cutaneous manifestations associated with unknown HIV infection: a case report
by: Paolo Iacovelli, et al.
Published: (2025-01-01)

Utility of CB-NAAT in cutaneous tuberculosis: A prospective observational study
by: Parul Verma, et al.
Published: (2025-03-01)

Cutaneous pseudolymphoma: a case series of three patients
by: Yue Yao, et al.
Published: (2025-01-01)

Cutaneous granulomas preceding peripheral cutaneous T-cell lymphoma NOS: A call for ongoing surveillance for late-onset malignancy
by: Selin Kolsuz, et al.
Published: (2024-12-01)

Stroke associated with microvascular tumoral infiltration in a patient with metastatic breast cancer
by: Joshua Mangerel, MD, et al.
Published: (2025-03-01)

Arteriovenous Fistula Pseudoaneurysm Mimicking Cutaneous a Neoplasm Arising from a Stenosed Arteriovenous Fistula
by: Hayato Hanada, et al.
Published: (2025-01-01)

Insights into the transmission cycle of cutaneous leishmaniasis from an endemic community in rural Guatemala
by: Yaimie Lopez, et al.
Published: (2025-01-01)

Kasr-Al-Ainy cutaneous lymphoma unit protocol for management of mycosis fungoides
by: Randa Youssef, et al.
Published: (2024-01-01)

Case Report: Severe acute pancreatitis accompanied by gastric mucosal exfoliation hemorrhage: clinical alerts and novel insights
by: Yanquan Liu, et al.
Published: (2025-01-01)